Physician

Dineshkumar Gordhanbhai Patel, M.B.B.S.

According to 2025 Medicare claims, Dineshkumar Patel, M.B.B.S. (NPI: 1316160161) practices cardiac surgery in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF BREVARD LLC (NPI: 1861400103; TIN: 593360315) and primary practice location at 32935-3166. Patel is affiliated with the Aledade A2909 FL MSSP Enhanced (ACO ID: A2909), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,404 traditional Medicare patients, billed 13,179 HCPCS/CPT codes, and received $928,653 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,769 prescription claims across 876 beneficiaries totaling $957,183 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 57 records totaling $2,672. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $363,157 to $928,653. Similarly, Part D prescription costs have moved sharply higher in recent years, from $42,266 to $957,183. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,116	4,750	$363,157
2016	996	3,551	$279,945
2017	770	4,226	$413,210
2018	959	8,780	$516,206
2019	974	6,621	$472,056
2020	968	6,442	$489,872
2021	1,455	7,570	$540,960
2022	1,304	11,199	$571,833
2023	1,324	11,136	$618,187
2024	1,404	13,179	$928,653

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	151	1,025	$42,266
2016	153	1,221	$60,825
2017	214	785	$50,143
2018	256	916	$87,069
2019	321	1,253	$184,258
2020	472	2,097	$286,490
2021	713	2,841	$434,075
2022	777	4,020	$749,718
2023	849	4,823	$975,434
2024	876	4,769	$957,183

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	433	446	$120
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	816	1,366	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	332	606	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	660	975	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	693	768	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	353	22,461	$419,347
Entresto	Sacubitril/Valsartan	171	11,070	$226,958
Xarelto	Rivaroxaban	99	6,245	$111,378
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	81	4,890	$23,484
Multaq	Dronedarone Hcl	14	1,020	$22,127

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$2,672	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dineshkumar Gordhanbhai Patel, M.B.B.S.?

Tedicare shows public-source Medicare data for Dineshkumar Gordhanbhai Patel, M.B.B.S. (NPI 1316160161), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dineshkumar Gordhanbhai Patel, M.B.B.S. have ACO affiliation data?

Dineshkumar Gordhanbhai Patel, M.B.B.S. is shown with ACO affiliation data for Aledade A2909 FL MSSP Enhanced (MSSP, ACO ID A2909).

What billing organization is linked to Dineshkumar Gordhanbhai Patel, M.B.B.S.?

Dineshkumar Gordhanbhai Patel, M.B.B.S. is linked to MEDICAL ASSOCIATES OF BREVARD LLC (billing NPI 1861400103) in the available physician profile data.

Does Dineshkumar Gordhanbhai Patel, M.B.B.S. have Open Payments data?

Dineshkumar Gordhanbhai Patel, M.B.B.S. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.